Top compounds associated with response to TMEM160


Feature Type Standardized
Nominal ANOVA
mRNA AZD6482 CTRPv2 pan-cancer AAC -0.0009 1
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.00075 1
mRNA tubastatin A GDSC1000 pan-cancer AAC -0.00055 1
mRNA Bexarotene CTRPv2 pan-cancer AAC -0.00052 1
mRNA HG-5-88-01 GDSC1000 pan-cancer AAC -0.00065 1
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.00042 1
mRNA BRD-K66532283 CTRPv2 pan-cancer AAC 0.00043 1
mRNA phloretin CTRPv2 pan-cancer AAC 0.00038 1
mRNA VAF-347 CTRPv2 pan-cancer AAC 0.00032 1
mRNA Z-LLNle-CHO GDSC1000 pan-cancer AAC -0.00027 1
Download CSV